shouldiuse.io

VERDICT

Should I use IntuitionLabs?

Implement governed AI one department at a time across pharma and biotech. Connect information, workflows, adoption, and measured value. - intuitionlabs.ai

Depends. Sensible for mid-size or large pharma/biotech with budget for a consulting-led, governed AI rollout. Not for anyone wanting self-serve software, public pricing, or products with independent reviews.

Confidence

Medium. Based on 20+ public sources; user-review and pricing evidence thin.

Ratings

  • Value for moneyNo public pricing
  • Ease of useNo user reviews found
  • Feature depth
  • Support qualityNo reviews mention support
  • Security posture

Pricing

Not disclosed

ModelNot disclosed
Monthly feesNot disclosed
HardwareNot disclosed

Best for

  • Mid-size pharma adopting AI department by department
  • Regulated life-sciences teams needing governance
  • Biotech without in-house AI staff

Not for

  • Small teams wanting simple self-serve tools
  • Startups needing software today on a budget
  • Buyers who require user reviews before purchasing
  • Non-life-sciences companies

Gotchas - check before you buy

medium

No published pricing — expect bespoke quotes negotiated in sales calls

medium

Zero G2 reviews means delivery quality cannot be verified before signing

medium

Guess: consultant-built workflows may create lock-in and painful handoffs later

low

Heavy content marketing (alternatives/case-study articles) — treat claims as advertising

Pros and cons

Pros

  • Specialist in regulated pharma AI: regulatory, pharmacovigilance, quality
  • Public client work documented, e.g. Scilex commercial operations
  • Publishes a security controls page
  • Department-by-department rollout ties AI to measured value

Cons

  • Zero G2 reviews; no independent buyer feedback
  • No public pricing; custom engagements only
  • Consultancy, not software — you buy people and process, not licenses
  • GSK/Amgen case-study tags look content-driven; verify who the client is

Sources & method

Analyzed 9/20/2026 - 10 sources - No known vulnerabilities found in the sources reviewed.

official x2review x4security x1news x3

Key stats

  • Feature depth: 3/5

    Rating

  • Not disclosed

    Starting price

  • 10

    Sources

  • Analyzed

  • Value for money. No public pricing
  • Ease of use. No user reviews found
  • Feature depth: 3/5. Broad pharma AI scope; depth unverified
  • Support quality. No reviews mention support
  • Security posture: 4/5. Publishes controls page; no breaches found
  • 0 G2 reviews No buyer feedback on G2
  • 7 Directory listings Clutch, GoodFirms, DesignRush, TechBehemoths and more
  • None Public pricing Custom engagement quotes only
  • Pharma & biotech Focus Department-by-department governed AI

Pricing

Not disclosed

Security

No known vulnerabilities found in the sources reviewed.

What users say

No independent user reviews exist; G2 lists zero reviews and directory profiles are sparse.

Companies that use it

  • Scilex Holding Company⁴

Companies that could

  • AstraZeneca⁸ Uses ChatGPT instead
Full analysis

Based on 20+ public sources; user-review and pricing evidence thin.

A pharma-focused AI consultancy, not off-the-shelf software. No pricing, no G2 reviews — fit depends on budget and appetite for services.

Methodology

Based on 20+ public sources; user-review and pricing evidence thin.

Sources

  1. IntuitionLabs Products | Read 0 Reviews on G2g2.com
    review
  2. IntuitionLabs Reviews & Ratingsgoodfirms.co
    review
  3. IntuitionLabs - Services & Company Infoclutch.co
    review
  4. Enhancing Scilex Holding Company's Commercial Operationstechreviewer.co
    review
  5. IntuitionLabs: AI Acceleration for Life Sciencesintuitionlabs.ai
    official
  6. Security at IntuitionLabs — Controls, Architecture & Practicesintuitionlabs.ai
    security
  7. IT Managed Servicesintuitionlabs.ai
    official
  8. AstraZeneca's ChatGPT Strategy: An Enterprise AI Case Studypostshift.com
    news
  9. How Automation and AI Transform Pharmacovigilancepharmaceuticalcommerce.com
    news
  10. Top Biopharmaceutical Business Intelligence Servicesdrugpatentwatch.com
    news

Rate this review

Anonymous. You can change your vote.

Loading votes…

Comments

One queue. No nested comments. Give a display name first. Limit: 200 words per comment and 7 comments per day. You can edit or delete yours.

Save a name to write a comment.

0 / 200 words

No comments yet.